ISPOR Announces Appointment of New Associate Chief Science Officer

Published Jan 22, 2018
Lucinda Strycker Orsini Joins the Society in New Science Role   Lawrenceville, NJ, USA—January 22, 2018—ISPOR, the professional society for health economics and outcomes research, announced today that Lucinda Strycker Orsini, DPM, MPH has joined the Society’s leadership team in the role of Associate Chief Science Officer. In this new role, Dr. Orsini will work closely with ISPOR’s Chief Science Officer, Richard J. Willke, PhD to direct, lead, and execute strategic initiatives related to research, scientific, and content priorities to advance the Society’s mission to promote health economics and outcomes research excellence to improve decision making for health globally. Dr. Orsini brings significant experience in the field of health economics and outcomes research (HEOR) to her new role at ISPOR. Her most recent position was as Vice President at Parexel where she led an HEOR team that provided a wide range of consulting services. Previously, Dr. Orsini worked at Bristol-Myers Squibb since 2005 where she held a variety of positions with increasing responsibility. Her most recent position at Bristol-Myers Squibb was Group Director in the worldwide HEOR group supporting oncology/immuno-oncology products. Previous to this, she was at Thomson Medstat where she worked extensively with real-world data studies. Dr. Orsini has her Doctor of Podiatric Medicine from Temple University, Master of Public Health from the Harvard T.H. Chan School of Public Health, and Bachelor of Science from Cornell University. “We are very excited to announce the appointment of Lucinda Orsini into the new role of Associate Chief Science Officer,” stated ISPOR’s Chief Science Officer Richard J. Willke, PhD. “Lucinda brings a wealth of experience in HEOR to her new role and will help advance the many strategic initiatives at the Society.”

###

  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg    

Related Stories

ISPOR Announces 2025-2026 Board of Directors

May 20, 2025

ISPOR announced the results of its recent elections and its 2025-2026 Board of Directors. The 2025-2026 board will assume office on July 1.

Value in Health Journal Spotlights "Whole Health" in Special Series

May 19, 2025

Value in Health, the official journal of ISPOR, announced the publication of a series of articles exploring the concept of "whole health"—a holistic approach to healthcare that extends beyond the traditional biomedical model to incorporate physical, mental, social, environmental, and spiritual dimensions of wellbeing.

Rethinking Medication Adherence: A Stakeholder Blueprint

May 12, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a report from its Medication Adherence and Persistence Special Interest Group that provides valuable insights into the perspectives of key stakeholders on interventions to improve medication adherence. The report, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report,” was published in the May 2025 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×